A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Maryland.
Mandatory Credit: Sarah Silbiger/Getty Images
Stories this photo appears in:
First Alzheimer’s drug to slow disease progression expected to get full FDA approval
The US Food and Drug Administration is expected to decide on Thursday whether to grant traditional approval to the Alzheimer’s drug Leqembi, the first medicine proven to slow the course of the memory-robbing disease.
